Parkinsonism in hiv-infected patients on highly active antiretroviral therapy.
Tisch
Stephen
S
Department of Neurology, St Vincent's Hospital, University of New South Wales, 390 Victoria Street, Darlinghurst, NSW 2010, Australia. stisch@stvincents.com.au
Brew
Bruce
B
D015526:AIDS Dementia Complex / Q000150:complications* / Q000188:drug therapy*; D000328:Adult; D017668:Age of Onset; D000375:Aging / Q000187:drug effects / Q000502:physiology; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015984:Causality; D018450:Disease Progression; D006801:Humans; D008297:Male; D008875:Middle Aged; D028361:Mitochondrial Diseases / Q000139:chemically induced / Q000378:metabolism / Q000821:virology; D009410:Nerve Degeneration / Q000139:chemically induced / Q000503:physiopathology / Q000821:virology; D009474:Neurons / Q000187:drug effects / Q000473:pathology / Q000821:virology; D020734:Parkinsonian Disorders / Q000139:chemically induced* / Q000503:physiopathology / Q000821:virology*; D012367:RNA, Viral / Q000032:analysis / Q000134:cerebrospinal fluid; D013378:Substantia Nigra / Q000187:drug effects / Q000503:physiopathology / Q000821:virology; D054875:Ubiquitination / Q000187:drug effects; D019562:Viral Load; D051844:alpha-Synuclein / Q000187:drug effects / Q000378:metabolism
D012367:RNA, Viral; D051844:alpha-Synuclein